The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

FASEB Journal

Volumn 19, Issue 11, 2005, Pages 1567-1569

  Jbilo, Omar ^a   Ravinet Trillou, Christine ^a   Arnone, Michèle ^a   Buisson, Isabelle ^a   Bribes, Estelle ^a   Péleraux, Annick ^a   Pénarier, Géraldine ^a   Soubrié, Philippe ^a   Le Fur, Gérard ^a   Galiègue, Sylvaine ^a   Casellas, Pierre ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENERGY BALANCE; FOOD INTAKE; GLYCOLYSIS; LIPID STORAGE; LIPOLYSIS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADIPOCYTES; ADIPONECTIN; ANIMALS; CYTOSKELETON; DIETARY FATS; ENERGY INTAKE; ENERGY METABOLISM; GENE EXPRESSION PROFILING; GLUCOSE; LIPOLYSIS; MALE; MICE; MICE, INBRED C57BL; OBESITY; PHENOTYPE; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; THERMOGENESIS;

ANIMALIA;

EID: 24644500204     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-3177fje     Document Type: Article

References (0)